AMR

R&D

The interconnected web of antimicrobial resistance

One world, one health: The interconnected web of antimicrobi...

Tackling antimicrobial resistance (AMR) requires a one health approach that joins the dots between the human, animal, and environmental drivers, consequences, and data.

Views & Analysis

Who will pay the price for inaction on superbugs?

While the UK government has been applauded for its efforts in raising awareness about antimicrobial resistance, its efforts to convince pharma to invest in new antibiotics have so far been

R&D

pharmaphorum podcast Matoke Pharma Alan Westwood

AMR research and Matoke Pharma: the pharmaphorum podcast

Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AM

News

FDA accepts Merck & Co's two new antibacterial drug applicat...

The FDA has accepted two new antibacterial drug applications from Merck & Co, both of which have received Priority Review.

News

NICE assessments could reform in new superbug plan

The UK government has published a new five year plan aimed at tackling antimicrobial resistance (AMR), including a new NHS reimbursement scheme backed by NICE to encourage pharma to develop

News